Sanofi to acquire Kymab for an upfront payment of approximately $1.1 billion

Continues to build on Sanofi’s leading presence in immunology aligned with strategy to pursue best-in-class treatments in defined areas PARIS: Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human…

NNR January 11, 2021

Euronext

Valneva appoints Perry Celentano as interim COO, David Lawrence as acting CFO

Valneva Strengthens Management Team; Appoints Perry Celentano as Interim COO and David Lawrence as Acting CFO SAINT-HERBLAIN: Valneva SE a specialty vaccine company focused on prevention against diseases with major…

NNR January 11, 2021

Euronext

Nanobiotix announces key development milestones for 2021 after successful Nasdaq IPO

PARIS: Nanobiotix announced its global development plan for 2021 and beyond. Nanobiotix will use a portion of the proceeds from the its IPO to launch its global phase III registration…

NNR January 8, 2021

Euronext

Celyad Oncology signs $40 million equity purchase agreement with Lincoln Park Capital

Net proceeds from the $40 million purchase agreement with LPC should help to extend the Company’s cash runway beyond the third quarter of 2021 BRUSSELS: Celyad Oncology SA has entered…

NNR January 7, 2021

Euronext

Advicenne hires Peter Meeus as Chief Executive Officer

PARIS: Advicenne announced the appointment of Peter Meeus as Chief Executive Officer of Advicenne, effective February 15, 2021. Dr. André Ulmann, who has been serving as interim CEO, will assume…

NNR January 7, 2021

Euronext

Heijmans sells 95 rental apartments in Noorderhaven project in Zutphen

AMSTERDAM: Heijmans has reached agreement with housing corporation Habion on the sale of ground and the realisation of 95 rental apartments in the Noorderhaven development in Zutphen. The start of…

NNR January 7, 2021

Euronext

Total will develop the LNG market in Benin

PARIS--(BUSINESS WIRE)-- Total, the Republic of Benin and the Société Béninoise d’Energie Electrique (SBEE) have signed the Gas Supply Agreement and the Host Government Agreement for the development of LNG…

NNR July 25, 2019

Euronext

Lonza expands Bioconjugation facility and announces approval of third commercial ADC

BASEL, SWITZERLAND: Lonza has announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the…

NNR July 24, 2019